A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer

被引：0

作者：

Folefac Aminkeng

Amit P Bhavsar

Henk Visscher

Shahrad R Rassekh

Yuling Li

Jong W Lee

Liam R Brunham

Huib N Caron

Elvira C van Dalen

Leontien C Kremer

Helena J van der Pal

Ursula Amstutz

Michael J Rieder

Daniel Bernstein

Bruce C Carleton

Michael R Hayden

Colin J D Ross

机构：

[1] Centre for Molecular Medicine and Therapeutics,Department of Medical Genetics

[2] University of British Columbia,Department of Pediatrics, Division of Translational Therapeutics

[3] Child and Family Research Institute,Department of Pediatrics

[4] University of British Columbia,Department of Pediatrics, Division of Pediatric Hematology/Oncology/Blood and Marrow Transplantation

[5] Amalia Children's Hospital,Department of Pediatric Oncology

[6] Radboud University Medical Center,Department of Medical Oncology

[7] University of British Columbia,Department of Pediatrics

[8] Translational Laboratory in Genetic Medicine,Division of Pediatric Cardiology

[9] National University of Singapore and Association for Science,undefined

[10] Technology and Research (A*STAR),undefined

[11] Emma Children's Hospital/Academic Medical Center,undefined

[12] Emma Children's Hospital/Academic Medical Center,undefined

[13] University of Western Ontario,undefined

[14] Stanford University,undefined

[15] Pharmaceutical Outcomes Programme,undefined

[16] British Columbia Children's Hospital,undefined

[17] Alberta Children's Hospital,undefined

[18] Calgary,undefined

[19] Stollery Children's Hospital,undefined

[20] Edmonton,undefined

[21] Winnipeg Health Sciences Centre,undefined

[22] London Health Sciences Centre,undefined

[23] McMaster Children's Hospital,undefined

[24] Hospital for Sick Children,undefined

[25] Kingston General Hospital,undefined

[26] Children's Hospital of Eastern Ontario,undefined

[27] CHU Sainte-Justine,undefined

[28] McGill University Health Centre–Montréal Children's Hospital,undefined

[29] IWK Health Centre,undefined

[30] Halifax,undefined

[31] Janeway Children's Hospital,undefined

[32] St. John's,undefined

[33] Present address: Institute of Clinical Chemistry,undefined

[34] Inselspital Bern University Hospital,undefined

[35] and University of Bern,undefined

[36] Bern,undefined

[37] Switzerland.,undefined

来源：

Nature Genetics | 2015年 / 47卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Colin Ross and colleagues report the results of a genome-wide association study of anthracycline-induced cardiotoxicity in children treated for cancer. They identify a nonsynonymous coding variant in RARG associated with roughly fivefold higher risk of developing this severe adverse drug reaction.

引用

页码：1079 / 1084

页数：5

共 50 条

[1] A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer
Aminkeng, Folefac
Bhavsar, Amit P.
Visscher, Henk
Rassekh, Shahrad R.
Li, Yuling
Lee, Jong W.
Brunham, Liam R.
Caron, Huib N.
van Dalen, Elvira C.
Kremer, Leontien C.
van der Pal, Helena J.
Amstutz, Ursula
Rieder, Michael J.
Bernstein, Daniel
Carleton, Bruce C.
Hayden, Michael R.
Ross, Colin J. D.
NATURE GENETICS, 2015, 47 (09) : 1079 - +
[2] PHARMACOGENOMIC STRATEGIES FOR THE PREVENTION OF ANTHRACYCLINE-INDUCED HEART FAILURE: A CODING VARIANT IN RARG CONFERS SUSCEPTIBILITY TO ANTHRACYCLINE-INDUCED CARDIOTOXICITY IN CHILDHOOD CANCER
Ross, Colin
DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S73 - S74
[3] Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancer
Aminkeng, Folefac
Ross, Colin J. D.
Rassekh, Shahrad R.
Rieder, Michael J.
Bhavsar, Amit P.
Sanatani, Shubhayan
Bernstein, Daniel
Hayden, Michael R.
Amstutz, Ursula
Carleton, Bruce C.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (05) : 1143 - 1145
[4] Protection from late-occurring anthracycline-related cardiotoxicity among childhood cancer survivors with a RARG coding variant
Tonorezos, Emily S.
Joseph, Vijai
Barnea, Dana
Villano, Danylo
Satagopan, Jaya
Friedman, Danielle Novetsky
Sklar, Charles A.
Oeffinger, Kevin C.
Offit, Kenneth
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (05)
[5] Anthracycline-induced cardiotoxicity
Ozdogru, Ibrahim
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2014, 42 (03): : 274 - 276
[6] Anthracycline-Induced Cardiotoxicity
Bannister, Clare
Kuhnl, Andrea
Potter, Victoria
McDonagh, Theresa
Kassam, Shireen
BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 : 115 - 116
[7] Anthracycline-induced cardiotoxicity: Cardiac MRI after treatment for childhood cancer
Oberholzer, K
Kunz, RP
Dittrich, M
Thelen, M
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2004, 176 (09): : 1245 - 1250
[8] Anthracycline-induced cardiotoxicity
Shan, K
Lincoff, AM
Young, JB
ANNALS OF INTERNAL MEDICINE, 1996, 125 (01) : 47 - 58
[9] Anthracycline-induced cardiotoxicity
Petit, T
BULLETIN DU CANCER, 2004, 91 : S159 - S165
[10] A Genetic Variant in RARG Informs Anthracycline-Induced Cardiotoxicity Risk Status in Pediatric Patients and a Viable Cardiac Protection Strategy
Hasbullah, J.
Bhavsar, A.
Gunaretnam, E.
Carleton, B.
Ross, C.
PEDIATRIC BLOOD & CANCER, 2020, 67 : S127 - S127

← 1 2 3 4 5 →